Cited by

• Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma.

  Diaz-Mercedes S, Archilla I, Camps J, de Lacy A, Gorostiaga I, Momblan D, Ibarzabal A, Maurel J, Chic N, Bombí JA, Balaguer F, Castells A, Aldecoa I, Borras JM, Cuatrecasas M. Diaz-Mercedes S, et al. Appl Health Econ Health Policy. 2019 Oct;17(5):655-667. doi: 10.1007/s40258-019-00482-7. Appl Health Econ Health Policy. 2019. PMID: 31115896 Free PMC article.
• Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.

  Tomita N, Kunieda K, Maeda A, Hamada C, Yamanaka T, Sato T, Yoshida K, Boku N, Nezu R, Yamaguchi S, Mishima H, Sadahiro S, Muro K, Ishiguro M, Sakamoto J, Saji S, Maehara Y. Tomita N, et al. Br J Cancer. 2019 Apr;120(7):689-696. doi: 10.1038/s41416-019-0410-0. Epub 2019 Mar 5. Br J Cancer. 2019. PMID: 30833647 Free PMC article. Clinical Trial.
• 3D spectral CT-based fusion model predicts prognosis and postoperative adjuvant chemotherapy benefit in locally advanced rectal cancer.

  Fan S, Liu J, Yang X, Qi L, Lu X, Liu H, Cui X. Fan S, et al. Sci Rep. 2025 Aug 6;15(1):28836. doi: 10.1038/s41598-025-14851-x. Sci Rep. 2025. PMID: 40770420 Free PMC article.
• Adjuvant chemotherapy in stage II-III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX.

  Ramaswamy A, Kothari R, Desouza A, Gupta T, Bairwa S, Kapoor A, Kumar A, Ventrapati P, Ramadwar M, Mandavkar S, Chavan N, Saklani A, Ostwal V. Ramaswamy A, et al. South Asian J Cancer. 2019 Jul-Sep;8(3):160-165. doi: 10.4103/sajc.sajc_176_18. South Asian J Cancer. 2019. PMID: 31489288 Free PMC article.
• Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer.

  Chen G, Peng J, Xiao Q, Wu HX, Wu X, Wang F, Li L, Ding P, Zhao Q, Li Y, Wang D, Shao Y, Bao H, Pan Z, Ding KF, Cai S, Wang F, Xu RH. Chen G, et al. J Hematol Oncol. 2021 May 17;14(1):80. doi: 10.1186/s13045-021-01089-z. J Hematol Oncol. 2021. PMID: 34001194 Free PMC article.